Controlling protein activity with ligand-regulated RNA aptamers

Chemistry and Biology

Volumn 9, Issue 8, 2002, Pages 907-913

  Vuyisich, Momchilo ^a   Beal, Peter A ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; DNA FORMAMIDOPYRIMIDINE GLYCOSYLASE; GLYCOSIDASE; LIGAND; NEOMYCIN; RNA;

ARTICLE; BINDING SITE; CHEMISTRY; COMBINATORIAL CHEMISTRY; CONFORMATION; DRUG ANTAGONISM; DRUG EFFECT; PROTEIN BINDING; PROTEIN FOOTPRINTING;

BACTERIAL PROTEINS; BINDING SITES; COMBINATORIAL CHEMISTRY TECHNIQUES; DNA-FORMAMIDOPYRIMIDINE GLYCOSYLASE; DRUG ANTAGONISM; LIGANDS; N-GLYCOSYL HYDROLASES; NEOMYCIN; NUCLEIC ACID CONFORMATION; PROTEIN BINDING; PROTEIN FOOTPRINTING; RNA;

BACTERIA (MICROORGANISMS);

EID: 0036669759     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(02)00185-0     Document Type: Article

References (42)

1. Malakoff D. Will a smaller genome complicate the patent chase? Science. 291:2001;1194.
2. Specht K.M., Shokat K.M. The emerging power of chemical genetics. Curr. Opin. Cell Biol. 14:2002;155-159.
3. Verdugo D.E., Cancilla M.T., Ge X., Gray N.S., Chang Y.T., Schultz P.G., Negishi M., Leary J.A., Bertozzi C.R. Discovery of estrogen sulfotransferase inhibitors from a purine library screen. J. Med. Chem. 44:2001;2683-2686.
4. Shen K., Keng Y.F., Wu L., Guo X.L., Lawrence D.S., Zhang Z.Y. Acquisition of a specific and potent PTP1B inhibitor from a novel combinatorial library and screening procedure. J. Biol. Chem. 276:2001;47311-47319.
5. McKenna J.M., Halley F., Souness J.E., McLay I.M., Pickett S.D., Collis A.J., Page K., Ahmed I. An algorithm-directed two-component library synthesized via solid-phase methodology yielding potent and orally bioavailable p38 MAP kinase inhibitors. J. Med. Chem. 45:2002;2173-2184.
6. Norman T.C., Gray N.S., Koh J.T., Schultz P.G. A structure-based library approach to kinase inhibitors. J. Am. Chem. Soc. 118:1996;7430-7431.
7. Kuruvilla F.G., Shamji A.F., Sternson S.M., Hergenrother P.J., Schreiber S.L. Dissecting glucose signaling with diversity-oriented synthesis and small-molecule microarrays. Nature. 416:2002;653-657.
8. Belshaw P.J., Schoepfer J.G., Liu K.-Q., Morrison K.L., Schreiber S.L. Rational design of orthogonal receptor-ligand combinations. Angew. Chem. Int. Ed. Engl. 34:1995;2129-2132.
9. Conrad R., Keranen L.M., Ellington A.D., Newton A.C. Isozyme-specific inhibition of protein kinase C by RNA aptamers. J. Biol. Chem. 269:1994;32051-32054.
10. Seiwert S.D., Nahreini T.S., Aigner S., Ahn N.G., Uhlenbeck O.C. RNA aptamers as pathway-specific MAP kinase inhibitors. Chem. Biol. 7:2000;833-843.
11. Wilson D.S., Szostak J.W. In vitro selection of functional nucleic acids. Annu. Rev. Biochem. 68:1999;611-647.
12. Famulok M., Blind M., Mayer G. Intramers as promising new tools in functional proteomics. Chem. Biol. 8:2001;931-939.
13. Blind M., Kolanus W., Famulok M. Cytoplasmic RNA modulators of an inside-out signal-transduction cascade. Proc. Natl. Acad. Sci. USA. 96:1999;3606-3610.
14. Shi H., Hoffman B.E., Lis J.T. RNA aptamers as effective protein antagonists in a multicellular organism. Proc. Natl. Acad. Sci. USA. 96:1999;10033-10038.
15. Thomas M., Chedin S., Carles C., Riva M., Famulok M., Sentenac A. Selective targeting and inhibition of yeast RNA polymerase II by RNA aptamers. J. Biol. Chem. 272:1997;27980-27986.
16. Werstuck G., Green M.R. Controlling gene expression in living cells through small molecule-RNA interactions. Science. 282:1998;296-298.
17. McCollum D., Gould K.L. Timing is everything. regulation of mitotic exit and cytokinesis by the MEN and SIN Trends Cell Biol. 11:2001;89-95.
18. Ambros V. Control of developmental timing in Caenorhabditis elegans. Curr. Opin. Genet. Dev. 10:2000;428-433.
19. Lee R.C., Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science. 294:2001;862-864.
20. Hermann T., Patel D.J. Adaptive recognition by nucleic acid aptamers. Science. 287:2000;820-825.
21. Jenison R.D., Gill S.C., Pardi A., Polisky B. High-resolution discrimination by RNA. Science. 263:1994;1425-1429.
22. Soukup G.A., Breaker R.R. Engineering precision RNA molecular switches. Proc. Natl. Acad. Sci. USA. 96:1999;3584-3589.
23. Robertson M.P., Ellington A.D. Design and optimization of effector-activated ribozyme ligases. Nucleic Acids Res. 28:2000;1751-1759.
24. Piganeau N., Jenne A., Thuillier V., Famulok M. An allosteric ribozyme regulated by doxycycline. Angew. Chem. Int. Ed. 39:2000;4369-4373.
25. Hartig J.S., Najafi-Shoushtari S.H., Grune I., Yan A., Ellington A.D., Famulok M. Protein-dependent ribozymes report molecular interactions in real time. Nat. Biotechnol. 20:2002;717-722.
26. Koizumi M., Soukup G.A., Kerr J.N.Q., Breaker R.R. Allosteric selection of ribozymes that respond to the second messengers cGMP and cAMP. Nat. Struct. Biol. 6:1999;1062-1071.
27. Chetsanga C.J., Lindahl T. Release of 7-methylguanine residues whose imidazole rings have been opened from damaged DNA by a DNA glycosylase from Escherichia coli. Nucleic Acids Res. 10:1979;3673-3684.
28. Boiteux S., O'Connor T.R., Lederer F., Gouyette A., Laval J. Homogeneous Escherichia coli FPG protein. A DNA glycosylase which excises imidazole ring-opened purines and nicks DNA at apurinic/apyrimidinic sites. J. Biol. Chem. 265:1990;3916-3922.
29. David S.S., Williams S.D. Chemistry of glycosylases and endonucleases involved in base-excision repair. Chem. Rev. 98:1998;1221-1261.
30. Tchou J., Kasai H., Shibutani S., Chung M.H., Laval J., Grollman A.P., Nishimura S. 8-Oxoguanine (8-hydroxyguanine) DNA glycosylase and its substrate specificity. Proc. Natl. Acad. Sci. USA. 88:1991;4690-4694.
31. Moazed D., Noller H.F. Interaction of antibiotics with functional sites in 16S ribosomal RNA. Nature. 327:1987;389-394.
32. Yoshizawa S., Fourmy D., Eason R.G., Puglisi J.D. Sequence-specific recognition of the major groove of RNA by deoxystreptamine. Biochemistry. 41:2002;6263-6270.
33. Carter A.P., Clemons W.M., Brodersen D.E., Morgan-Warren R.J., Wimberly B.T., Ramakrishnan V. Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature. 407:2000;340-348.
34. Wallis M.G., von Ahsen U., Schroeder R., Famulok M. A novel RNA motif for neomycin recognition. Chem. Biol. 2:1995;543-552.
35. Leipold M.D., Muller J.G., Burrows C.J., David S.S. Removal of hydantoin products of 8-oxoguanine oxidation by the Escherichia coli DNA repair enzyme, FPG. Biochemistry. 39:2000;14984-14992.
36. Zharkov D.O., Rieger R.A., Iden C.R., Grollman A.P. NH2-terminal proline acts as a nucleophile in the glycosylase/ AP-lyase reaction catalyzed by Escherichia coli formamidopyrimidine-DNA glycosylase (Fpg) protein. J. Biol. Chem. 272:1997;5335-5342.
37. Mathews D.H., Sabina J., Zuker M., Turner D.H. Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J. Mol. Biol. 288:1999;911-940.
38. Leach B.E., DeVries W.H., Nelson H.A., Jackson W.G., Evans J.S. The isolation and characterization of neomycin. J. Am. Chem. Soc. 73:1951;2797-2800.
39. Ellington A.D., Szostak J.W. In vitro selection of RNA molecules that bind specific ligands. Nature. 346:1990;818-822.
40. Hermann T. Strategies for the design of drugs targeting RNA and RNA-protein complexes. Angew. Chem. Int. Ed. 39:2000;1890-1905.
41. Abelson J.N. Combinatorial chemistry. Methods Enzymol. 267:1996;291-335.
42. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning. A Laboratory Manual:1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.